The cardiac rhythm management industry looks like it needs of a jolt of its own, badly.
A look at the earnings releases of two of the big three players in the CRM Market, Boston Scientific (NYSE:BSX) and St. Jude Medical (NYSE:STJ), reveals that the slump in the cardiac rhythm management business is more persistent than some industry observers initially thought.